Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive use of Emdogain FL in non-surgical therapy of initial peri-implantitis
TCTR20250513007Phase 3Completed
- Sponsor
- Straumann
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enamel matrix derivative in peri-implantitis, sponsored by Straumann. Started Jan 2025; status: completed.
02
Drugs
enamel matrix derivative
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on TCTR20250513007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250513007.